Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodium

gan Konovalova, Irina S., Kovalenko, Sergiy M., Kravchenko, Dmitry V., Chuev, Vladimir P.
Cyhoeddwyd yn Acta Crystallogr E Crystallogr Commun (2021)

(1R,3S)-3-(1H-Benzo[d]imidazol-2-yl)-1,2,2-tri­methyl­cyclo­pentane-1-carb­oxy­lic acid as a new anti-diabetic active pharmaceutical ingredient

gan Kovalenko, Sergiy M., Konovalova, Irina S., Merzlikin, Sergiy I., Chuev, Vladimir P., Kravchenko, Dmitry V.
Cyhoeddwyd yn Acta Crystallogr E Crystallogr Commun (2020)

Crystal structure, Hirshfeld analysis and a mol­ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa­diazo...

gan Ivachtchenko, Alexandre V., Kovalenko, Sergiy M., Kravchenko, Dmitry V., Mitkin, Oleg D., Ivanov, Vladimir V., Langer, Thierry
Cyhoeddwyd yn Acta Crystallogr E Crystallogr Commun (2020)

Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophe...

gan Ivachtchenko, Alexandre V., Mitkin, Oleg D., Kravchenko, Dmitry V., Kovalenko, Sergiy M., Shishkina, Svitlana V., Bunyatyan, Natalya D., Konovalova, Irina S., Dmitrieva, Irina G., Ivanov, Vladimir V., Langer, Thierry
Cyhoeddwyd yn Heliyon (2019)

Methylation of Methyl 4-Hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate: Synthetic, Crystallographic, and Molecular Docking Studies

gan Kovalenko, Sergiy M., Drushlyak, Oleksandr G., Shishkina, Svitlana V., Konovalova, Irina S., Mariutsa, Illia O., Bunyatyan, Natalya D., Kravchenko, Dmitry V., Ivanov, Vladimir V., Ivachtchenko, Alexandre V., Langer, Thierry
Cyhoeddwyd yn Molecules (2020)

Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment

gan Ivachtchenko, Alexandre V., Mitkin, Oleg D., Kudan, Elizaveta V., Rjahovsky, Alexey A., Vorobiev, Anton A., Trifelenkov, Andrey S., Shevkun, Natalia A., Proskurina, Oxana V., Kravchenko, Dmitry V., Karapetian, Ruben N.
Cyhoeddwyd 2014

Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir

gan Ivashchenko, Andrei A, Mitkin, Oleg D, Jones, Jeremy C, Nikitin, Alexander V, Koryakova, Angela G, Karapetian, Ruben N, Kravchenko, Dmitry V, Mochalov, Stephan V, Ryakhovskiy, Alexey A, Aladinskiy, Vladimir, Leneva, Irina A, Falynskova, Irina N, Glubokova, Ekaterina A, Govorkova, Elena A, Ivachtchenko, Alexandre V
Cyhoeddwyd yn J Antimicrob Chemother (2020)

Effect of Aprotinin and Avifavir(®) Combination Therapy for Moderate COVID-19 Patients

gan Ivashchenko, Andrey A., Azarova, Valeria N., Egorova, Alina N., Karapetian, Ruben N., Kravchenko, Dmitry V., Krivonos, Natalia V., Loginov, Vladimir G., Poyarkov, Stanislav V., Merkulova, Elena A., Rosinkova, Olga S., Savchuk, Nikolay P., Topr, Mikhail A., Simakina, Elena N., Yakubova, Elena V., Ivachtchenko, Alexandre V.
Cyhoeddwyd yn Viruses (2021)

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

gan Ivashchenko, Andrey A, Dmitriev, Kirill A, Vostokova, Natalia V, Azarova, Valeria N, Blinow, Andrew A, Egorova, Alina N, Gordeev, Ivan G, Ilin, Alexey P, Karapetian, Ruben N, Kravchenko, Dmitry V, Lomakin, Nikita V, Merkulova, Elena A, Papazova, Natalia A, Pavlikova, Elena P, Savchuk, Nikolay P, Simakina, Elena N, Sitdekov, Tagir A, Smolyarchuk, Elena A, Tikhomolova, Elena G, Yakubova, Elena V, Ivachtchenko, Alexandre V
Cyhoeddwyd yn Clin Infect Dis (2020)